Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
University of California San Francisco (UCSF), San Francisco, California Regents of the University of Colorado, Aurora, Colorado Yale University, New Haven, Connecticut University of Texas M.D. Anderson Cancer Center, Houston, Texas